Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1995 Aug;63(8):3054–3061. doi: 10.1128/iai.63.8.3054-3061.1995

The outer membranes of Brucella spp. are resistant to bactericidal cationic peptides.

G Martínez de Tejada 1, J Pizarro-Cerdá 1, E Moreno 1, I Moriyón 1
PMCID: PMC173416  PMID: 7622230

Abstract

The actions of polymyxin B, rabbit polymorphonuclear lysosome extracts, 14 polycationic peptides (including defensin NP-2, cecropin P1, lactoferricin B, and active peptides from cationic protein 18 and bactenecin), EDTA, and Tris on Brucella spp. were studied, with other gram-negative bacteria as controls. Brucella spp. were comparatively resistant to all of the agents listed above and bound less polymyxin B, and their outer membranes (OMs) were neither morphologically altered nor permeabilized to lysozyme by polymyxin B concentrations, although both effects were observed for controls. EDTA and peptides increased or accelerated the partition of the hydrophobic probe N-phenyl-naphthylamine into Escherichia coli and Haemophilus influenzae OMs but had no effect on Brucella OMs. Since Brucella and H. influenzae OMs are permeable to hydrophobic compounds (G. Martínez de Tejada and I. Moriyón, J. Bacteriol. 175:5273-5275, 1993), the results show that such unusual permeability is not necessarily related to resistance to polycations. Although rough (R) B. abortus and B. ovis were more resistant than the controls were, there were qualitative and quantitative differences with smooth (S) brucellae; this may explain known host range and virulence differences. Brucella S-lipopolysaccharides (LPSs) had reduced affinities for polycations, and insertion of Brucella and Salmonella montevideo S-LPSs into the OM of a Brucella R-LPS mutant increased and decreased, respectively, its resistance to cationic peptides. The results show that the core lipid A of Brucella LPS plays a major role in polycation resistance and that O-chain density also contributes significantly. It is proposed that the features described above contribute to Brucella resistance to the oxygen-independent systems of phagocytes.

Full Text

The Full Text of this article is available as a PDF (578.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Boman H. G., Faye I., Gudmundsson G. H., Lee J. Y., Lidholm D. A. Cell-free immunity in Cecropia. A model system for antibacterial proteins. Eur J Biochem. 1991 Oct 1;201(1):23–31. doi: 10.1111/j.1432-1033.1991.tb16252.x. [DOI] [PubMed] [Google Scholar]
  2. Capodici C., Chen S., Sidorczyk Z., Elsbach P., Weiss J. Effect of lipopolysaccharide (LPS) chain length on interactions of bactericidal/permeability-increasing protein and its bioactive 23-kilodalton NH2-terminal fragment with isolated LPS and intact Proteus mirabilis and Escherichia coli. Infect Immun. 1994 Jan;62(1):259–265. doi: 10.1128/iai.62.1.259-265.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. David S. A., Mathan V. I., Balaram P. Interaction of melittin with endotoxic lipid A. Biochim Biophys Acta. 1992 Feb 12;1123(3):269–274. doi: 10.1016/0005-2760(92)90006-h. [DOI] [PubMed] [Google Scholar]
  4. Ellison R. T., 3rd, Giehl T. J. Killing of gram-negative bacteria by lactoferrin and lysozyme. J Clin Invest. 1991 Oct;88(4):1080–1091. doi: 10.1172/JCI115407. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Gennaro R., Skerlavaj B., Romeo D. Purification, composition, and activity of two bactenecins, antibacterial peptides of bovine neutrophils. Infect Immun. 1989 Oct;57(10):3142–3146. doi: 10.1128/iai.57.10.3142-3146.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Groisman E. A. How bacteria resist killing by host-defense peptides. Trends Microbiol. 1994 Nov;2(11):444–449. doi: 10.1016/0966-842x(94)90802-8. [DOI] [PubMed] [Google Scholar]
  7. Hanke W., Methfessel C., Wilmsen H. U., Katz E., Jung G., Boheim G. Melittin and a chemically modified trichotoxin form alamethicin-type multi-state pores. Biochim Biophys Acta. 1983 Jan 5;727(1):108–114. doi: 10.1016/0005-2736(83)90374-7. [DOI] [PubMed] [Google Scholar]
  8. Hirata M., Shimomura Y., Yoshida M., Morgan J. G., Palings I., Wilson D., Yen M. H., Wright S. C., Larrick J. W. Characterization of a rabbit cationic protein (CAP18) with lipopolysaccharide-inhibitory activity. Infect Immun. 1994 Apr;62(4):1421–1426. doi: 10.1128/iai.62.4.1421-1426.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Hovde C. J., Gray B. H. Characterization of a protein from normal human polymorphonuclear leukocytes with bactericidal activity against Pseudomonas aeruginosa. Infect Immun. 1986 Oct;54(1):142–148. doi: 10.1128/iai.54.1.142-148.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Kagan B. L., Selsted M. E., Ganz T., Lehrer R. I. Antimicrobial defensin peptides form voltage-dependent ion-permeable channels in planar lipid bilayer membranes. Proc Natl Acad Sci U S A. 1990 Jan;87(1):210–214. doi: 10.1073/pnas.87.1.210. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Kuhn H. M., Basu S., Mayer H. Comparison of enterobacterial common antigen from different species by serological techniques. Eur J Biochem. 1987 Jan 2;162(1):69–74. doi: 10.1111/j.1432-1033.1987.tb10543.x. [DOI] [PubMed] [Google Scholar]
  12. Lee J. Y., Boman A., Sun C. X., Andersson M., Jörnvall H., Mutt V., Boman H. G. Antibacterial peptides from pig intestine: isolation of a mammalian cecropin. Proc Natl Acad Sci U S A. 1989 Dec;86(23):9159–9162. doi: 10.1073/pnas.86.23.9159. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Lehrer R. I., Lichtenstein A. K., Ganz T. Defensins: antimicrobial and cytotoxic peptides of mammalian cells. Annu Rev Immunol. 1993;11:105–128. doi: 10.1146/annurev.iy.11.040193.000541. [DOI] [PubMed] [Google Scholar]
  14. Martínez de Tejada G., Moriyón I. The outer membranes of Brucella spp. are not barriers to hydrophobic permeants. J Bacteriol. 1993 Aug;175(16):5273–5275. doi: 10.1128/jb.175.16.5273-5275.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Moreno E., Berman D. T., Boettcher L. A. Biological activities of Brucella abortus lipopolysaccharides. Infect Immun. 1981 Jan;31(1):362–370. doi: 10.1128/iai.31.1.362-370.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Moreno E., Stackebrandt E., Dorsch M., Wolters J., Busch M., Mayer H. Brucella abortus 16S rRNA and lipid A reveal a phylogenetic relationship with members of the alpha-2 subdivision of the class Proteobacteria. J Bacteriol. 1990 Jul;172(7):3569–3576. doi: 10.1128/jb.172.7.3569-3576.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Moriyon I., Berman D. T. Effects of nonionic, ionic, and dipolar ionic detergents and EDTA on the Brucella cell envelope. J Bacteriol. 1982 Nov;152(2):822–828. doi: 10.1128/jb.152.2.822-828.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Morris J. A. The interaction of "Brucella abortus" 544 and neutrophil polymorphonuclear leucocytes. Ann Sclavo. 1977 Jan-Feb;19(1):143–150. [PubMed] [Google Scholar]
  19. Peterson A. A., Haug A., McGroarty E. J. Physical properties of short- and long-O-antigen-containing fractions of lipopolysaccharide from Escherichia coli 0111:B4. J Bacteriol. 1986 Jan;165(1):116–122. doi: 10.1128/jb.165.1.116-122.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Pierce A., Colavizza D., Benaissa M., Maes P., Tartar A., Montreuil J., Spik G. Molecular cloning and sequence analysis of bovine lactotransferrin. Eur J Biochem. 1991 Feb 26;196(1):177–184. doi: 10.1111/j.1432-1033.1991.tb15801.x. [DOI] [PubMed] [Google Scholar]
  21. Piers K. L., Brown M. H., Hancock R. E. Improvement of outer membrane-permeabilizing and lipopolysaccharide-binding activities of an antimicrobial cationic peptide by C-terminal modification. Antimicrob Agents Chemother. 1994 Oct;38(10):2311–2316. doi: 10.1128/aac.38.10.2311. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Piers K. L., Hancock R. E. The interaction of a recombinant cecropin/melittin hybrid peptide with the outer membrane of Pseudomonas aeruginosa. Mol Microbiol. 1994 Jun;12(6):951–958. doi: 10.1111/j.1365-2958.1994.tb01083.x. [DOI] [PubMed] [Google Scholar]
  23. Rana F. R., Blazyk J. Interactions between the antimicrobial peptide, magainin 2, and Salmonella typhimurium lipopolysaccharides. FEBS Lett. 1991 Nov 18;293(1-2):11–15. doi: 10.1016/0014-5793(91)81141-t. [DOI] [PubMed] [Google Scholar]
  24. Rasool O., Freer E., Moreno E., Jarstrand C. Effect of Brucella abortus lipopolysaccharide on oxidative metabolism and lysozyme release by human neutrophils. Infect Immun. 1992 Apr;60(4):1699–1702. doi: 10.1128/iai.60.4.1699-1702.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Riley L. K., Robertson D. C. Brucellacidal activity of human and bovine polymorphonuclear leukocyte granule extracts against smooth and rough strains of Brucella abortus. Infect Immun. 1984 Oct;46(1):231–236. doi: 10.1128/iai.46.1.231-236.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Riley L. K., Robertson D. C. Ingestion and intracellular survival of Brucella abortus in human and bovine polymorphonuclear leukocytes. Infect Immun. 1984 Oct;46(1):224–230. doi: 10.1128/iai.46.1.224-230.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Rojas N., Freer E., Weintraub A., Ramirez M., Lind S., Moreno E. Immunochemical identification of Brucella abortus lipopolysaccharide epitopes. Clin Diagn Lab Immunol. 1994 Mar;1(2):206–213. doi: 10.1128/cdli.1.2.206-213.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Sawyer J. G., Martin N. L., Hancock R. E. Interaction of macrophage cationic proteins with the outer membrane of Pseudomonas aeruginosa. Infect Immun. 1988 Mar;56(3):693–698. doi: 10.1128/iai.56.3.693-698.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Schurig G. G., Roop R. M., 2nd, Bagchi T., Boyle S., Buhrman D., Sriranganathan N. Biological properties of RB51; a stable rough strain of Brucella abortus. Vet Microbiol. 1991 Jul;28(2):171–188. doi: 10.1016/0378-1135(91)90091-s. [DOI] [PubMed] [Google Scholar]
  30. Selsted M. E., Szklarek D., Lehrer R. I. Purification and antibacterial activity of antimicrobial peptides of rabbit granulocytes. Infect Immun. 1984 Jul;45(1):150–154. doi: 10.1128/iai.45.1.150-154.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Sipos D., Andersson M., Ehrenberg A. The structure of the mammalian antibacterial peptide cecropin P1 in solution, determined by proton-NMR. Eur J Biochem. 1992 Oct 1;209(1):163–169. doi: 10.1111/j.1432-1033.1992.tb17273.x. [DOI] [PubMed] [Google Scholar]
  32. Spitznagel J. K. Antibiotic proteins of human neutrophils. J Clin Invest. 1990 Nov;86(5):1381–1386. doi: 10.1172/JCI114851. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Stinavage P., Martin L. E., Spitznagel J. K. O antigen and lipid A phosphoryl groups in resistance of Salmonella typhimurium LT-2 to nonoxidative killing in human polymorphonuclear neutrophils. Infect Immun. 1989 Dec;57(12):3894–3900. doi: 10.1128/iai.57.12.3894-3900.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Takada K., Ohno N., Yadomae T. Binding of lysozyme to lipopolysaccharide suppresses tumor necrosis factor production in vivo. Infect Immun. 1994 Apr;62(4):1171–1175. doi: 10.1128/iai.62.4.1171-1175.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Thiele O. W., Schwinn G. The free lipids of Brucella melitensis and Bordetella pertussis. Eur J Biochem. 1973 Apr;34(2):333–344. doi: 10.1111/j.1432-1033.1973.tb02764.x. [DOI] [PubMed] [Google Scholar]
  36. Tsai C. M., Frasch C. E. A sensitive silver stain for detecting lipopolysaccharides in polyacrylamide gels. Anal Biochem. 1982 Jan 1;119(1):115–119. doi: 10.1016/0003-2697(82)90673-x. [DOI] [PubMed] [Google Scholar]
  37. Vaara M. Agents that increase the permeability of the outer membrane. Microbiol Rev. 1992 Sep;56(3):395–411. doi: 10.1128/mr.56.3.395-411.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. WARREN G. H., GRAY J., YURCHENCO J. A. Effect of polymyxin on the lysis of Neisseria catarrhalis by lysozyme. J Bacteriol. 1957 Dec;74(6):788–793. doi: 10.1128/jb.74.6.788-793.1957. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Weber A., Schiefer H. G., Krauss H. Elektronenmikroskopische Differenzierung der S- und R-Formen von Brucellen durch Behandlung mit polykationischem Ferritin. Zentralbl Veterinarmed B. 1978 May;25(4):324–328. [PubMed] [Google Scholar]
  40. Yamauchi K., Tomita M., Giehl T. J., Ellison R. T., 3rd Antibacterial activity of lactoferrin and a pepsin-derived lactoferrin peptide fragment. Infect Immun. 1993 Feb;61(2):719–728. doi: 10.1128/iai.61.2.719-728.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES